BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29258453)

  • 1. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
    Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
    BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
    Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
    Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
    Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
    PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
    Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
    Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
    Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
    Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
    Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer.
    Dooley LN; Ganz PA; Cole SW; Crespi CM; Bower JE
    J Affect Disord; 2016 Jun; 197():43-50. PubMed ID: 26967918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study.
    Buchmann AF; Hellweg R; Rietschel M; Treutlein J; Witt SH; Zimmermann US; Schmidt MH; Esser G; Banaschewski T; Laucht M; Deuschle M
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):902-9. PubMed ID: 23058261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Mak M; Deptuła-Jarosz M; Gołąb-Janowska M; Droździk M; Sławek J
    Neurosci Lett; 2014 Feb; 561():86-90. PubMed ID: 24394906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of BDNF rs6265 variants and energy and protein intake in the risk for glucose intolerance and type 2 diabetes in middle-aged adults.
    Daily JW; Park S
    Nutrition; 2017 Jan; 33():187-194. PubMed ID: 27553771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.
    Ng DQ; Cheng I; Wang C; Tan CJ; Toh YL; Koh YQ; Ke Y; Foo KM; Chan RJ; Ho HK; Chew L; Bin Harunal Rashid MF; Chan A
    Sci Rep; 2023 Sep; 13(1):16298. PubMed ID: 37770565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF Val66Met homozygosity does not influence plasma BDNF levels in healthy human subjects.
    Luykx JJ; Boks MP; Breetvelt EJ; Aukes MF; Strengman E; da Pozzo E; Dell'osso L; Marazziti D; van Leeuwen A; Vreeker A; Abramovic L; Martini C; Numans ME; Kahn RS; Ophoff RA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():185-7. PubMed ID: 23269345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
    Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
    Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome.
    Zhang QY; Guan Q; Wang Y; Feng X; Sun W; Kong FY; Wen J; Cui W; Yu Y; Chen ZY
    Hum Reprod; 2012 Jun; 27(6):1668-75. PubMed ID: 22447624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
    Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BDNF Val
    Jasińska KK; Molfese PJ; Kornilov SA; Mencl WE; Frost SJ; Lee M; Pugh KR; Grigorenko EL; Landi N
    Behav Brain Res; 2017 Jun; 328():48-56. PubMed ID: 28359883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
    Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
    Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
    Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
    Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.